Vascular Closure Devices with Transfemoral PCI: Are They Worthwhile?

In a large registry study, risks for vascular complications and transfusion were significantly lower with VCDs than with manual closure.

Vascular closure devices (VCDs) are commonly used in percutaneous coronary intervention (PCI), despite conflicting evidence of benefit. To examine the effects of these devices, investigators used propensity-score matching to analyze data from 32 hospitals participating in the Blue Cross Blue Shield of Michigan Cardiovascular Consortium quality study. Of 85,048 PCI procedures, VCDs were employed in 28,528 (37%). The rate of VCD use among the participating institutions ranged from 0% to 83%. Compared with patients treated with manual closure, those treated with VCDs were significantly younger and less likely to have comorbidities or to be undergoing primary PCI.

Compared with manual closure, VCDs were associated with significant reductions in …

Reviewing Author

Joel M. Gore, MD

Disclosures

Grant/Research SupportNIH–National Heart, Lung, and Blood Institute

Joel M. Gore, MD

Disclosures

Grant/Research SupportNIH–National Heart, Lung, and Blood Institute

Vascular Closure Devices with Transfemoral PCI: Are They Worthwhile?

Topics

Reviewing Author